Price, one year
Price range
- Open
- ₹1,332.40
- High
- ₹1,338.00
- Low
- ₹1,314.10
- Previous close
- ₹1,330.90
- Volume
- 13.2 L
- Market cap
- ₹1,08,093 Cr
Key statistics
Results to 30 Jun 2026 · Consolidated- P/E (TTM)
- 32.1
- Price to book
- 3.1
- Return on equity
- 9.8%
- EPS (TTM)
- ₹41.74
- Book value / share
- ₹426.21
- Debt to equity
- 0.01
- Revenue (TTM)
- ₹28,324 Cr
- Net profit (TTM)
- ₹3,371 Cr
- Sales growth, YoY
- +2.3%
- Profit growth, YoY
- −39.2%
- Operating margin
- 18.7%
- Net margin
- 11.9%
- Sales CAGR, 3 years
- +7.4%
- Profit CAGR, 3 years
- +11.4%
- Promoter holding
- 29.21%
- Promoter shares pledged
- 0.00%
Shareholding pattern
% of shares| Holder | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 29.21 | 29.21 | 29.21 |
| Foreign institutions | 22.56 | 20.21 | 20.25 |
| Domestic institutions | 31.97 | 34.63 | 34.94 |
| Mutual funds | 18.66 | 20.56 | 20.78 |
| Retail and others | 13.98 | 13.73 | 13.41 |
Futures and options
23 Oct 2026- Lot size
- 425
- Put-call ratio (OI)
- 0.69
- Max pain
- ₹1,340.00
- Highest call OI strike
- 1,450.00
- Highest put OI strike
- 1,220.00
- ATM implied volatility
- 27.9% IV rank 66
- Futures basis
- −0.78%
- Rollover
- 72.0%
Futures open interest, last sessions
| Date | Build-up | Price | OI change |
|---|---|---|---|
| 23 Oct | Short buildup | −0.02% | +0.46% |
| 22 Oct | Long buildup | +1.34% | +1.80% |
| 21 Oct | Short buildup | −1.03% | +4.23% |
| 19 Oct | Short buildup | −0.05% | +0.81% |
| 16 Oct | Short buildup | −0.17% | +0.37% |
Option figures are for the 27 Oct 2026 expiry.
Results and announcements
Latest results (quarter to 30 Jun 2026) filed 23 Jul 2026. results: 27 Oct 2026.
Peers in Healthcare
All Healthcare stocks| Company | Price | Change |
|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | ₹1,748.00 | −0.57% |
| Divi's LaboratoriesDIVISLAB | ₹8,950.00 | −2.31% |
| Torrent PharmaceuticalsTORNTPHARM | ₹4,524.40 | −1.97% |
| Zydus LifesciencesZYDUSLIFE | ₹1,129.40 | −0.49% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | ₹7,730.00 | +1.65% |
| Laurus LabsLAURUSLABS | ₹1,970.00 | −1.62% |
| Dr. Reddy's LaboratoriesDRREDDY | ₹1,229.50 | −0.77% |
| Mankind PharmaMANKIND | ₹2,212.60 | −2.77% |
| Aurobindo PharmaAUROPHARMA | ₹1,571.70 | −2.43% |
| LupinLUPIN | ₹1,928.90 | +0.36% |
Frequently asked questions
What is the share price of Cipla today?
Cipla (NSE: CIPLA) was at ₹1,338.00 on 23 Oct 2026, a change of +0.53% from the previous close.
What are the 52-week high and low of Cipla?
Over the last 52 weeks Cipla traded between ₹1,165.70 and ₹1,673.00 (daily highs and lows on NSE on 23 Oct 2026).
What is the market capitalisation of Cipla?
About ₹1,08,093 Cr at the latest price, with a P/E of 32.1, a price-to-book of 3.1, a return on equity of 9.8%. Ratios use the company's latest reported results.
Who owns Cipla shares?
According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 29.21%, foreign institutions 20.25%, domestic institutions 34.94%.
Is Cipla traded in futures and options?
Yes, CIPLA is in NSE's futures and options segment. The lot size is 425 shares.
Which sector and indices does Cipla belong to?
NSE classifies Cipla under Healthcare; it is a member of Nifty 50, Nifty 100, Nifty 500.
Follow Cipla with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.
Start free trial